The global bone densitometers market boasts a total value of $299 million in 2022 and is projected to register a growth rate of 4.7% to reach a value of $378 million by 2027.

Factors such as the increasing prevalence of osteoporosis and the growing geriatric population are expected to drive the growth of this market during the forecast period. However, the high cost of bone densitometers is expected to restrain the growth of this market during the forecast period.

By Technology, the Axial Bone Densitometry segment is expected to account for the largest share of the Bone Densitometer market

The axial bone densitometry segment accounted for the largest share the bone densitometer market in 2021. The large share of this segment can be attributed to the advantages of DEXA scanners over peripheral bone densitometers. Moreover, the results obtained from DEXA scanners can be interpreted using WHO scores for greater accuracy.

By Application, the Osteoporosis & Osteopenia Diagnosis segment is expected to account for the largest share of the Bone Densitometer market

The osteoporosis & osteopenia diagnosis accounted for the largest share of the global bone densitometer market in 2021. The large share of this segment can be attributed to the growing geriatric population and the subsequent increase in the prevalence of osteoporosis, the increasing risk of osteoporosis in menopausal women, and the growing global incidence of fragility fractures.

By End User, the Hospitals & Specialty Clinics segment is expected to account for the largest share of the Bone Densitometer market

The hospitals & specialty clinics segment accounted for the largest share of the global bone densitometer market in 2021. The large share of this segment can be attributed to the higher preference of patients for hospital-based treatment of diseases such as cystic fibrosis, chronic kidney disease, and osteoporosis.

North America dominated this market with the largest share in 2021

In 2021, North America dominated this market with the largest share. This can be attributed to the high consumer awareness, rising healthcare expenditure, the increasing prevalence of osteoporosis, and the presence of key market players in the region.

Some of the prominent players operating in the global bone densitometers market are GE Healthcare (US), Hologic, Inc. (US), OSI Systems, Inc. (US), Diagnostic Medical Systems Group (France), Swissray Global Healthcare Holding, Ltd. (Taiwan), BeamMed, Ltd. (Israel), Echolight S.P.A (Italy), Scanflex Healthcare AB (Sweden), Medonica Co., Ltd. (South Korea), Eurotec Systems S.r.l (Italy), AMPall Co., Ltd. (South Korea), L’acn L’accessorio Nucleare S.R.L (Italy), Shenzhen XRAY Electric Co., Ltd. (China), YOZMA BMTech Co., Ltd. (South Korea), Nanoomtech Co., Ltd. (South Korea), Osteosys Corporation (South Korea), FURUNO Electric Co., Ltd. (Japan), Xianyang Kanrota Digital Ultrasound System, Co., Ltd. (China), XinGaoYi Co., Ltd. (China), Anjue Medical Equipment (China), Guangzhou Medsinglong Medical Equipment Co., Ltd. (China), Trivitron Healthcare (India), OsCare Medical Oy (Finland), CyberLogic, Inc. (US), and Nanjing Kejin Industrial Co., Ltd. (China).